Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Efficacy of Gegen Qinlian Tang Combined with Bifidobacterium Triple Viable Capsules in the Prevention and Treatment of Radiation Enteritis

NCT06836960 is registered in ClinicalTrials.gov with Jiujiang No.1 People's Hospital as lead sponsor.

NCT NCT06836960
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06836960 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Efficacy of Gegen Qinlian Tang Combined with Bifidobacterium Triple Viable Capsules in the Prevention and Treatment of Radiation Enteritis
Lead sponsor
Jiujiang No.1 People's Hospital
Phase
Phase 1/2
Overall status
Enrolling by invitation
Start date
June 1, 2025
Completion date
December 31, 2026
Enrollment
60 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

acute radiation enteritis